Clinical Trial Update: Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in newly diagnosed stage III/IV ovarian cancer evaluating neoadjuvant carboplatin/paclitaxel/pembrolizumab followed by maintenance olapar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• KEYTRUDA (PEMBROLIZUMAB)
• Lynparza (olaparib)
• Taxol (paclitaxel)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Ovarian Cancer | Phase 2 | Status: RECRUITING